tiprankstipranks
iCAD Inc (ICAD)
:ICAD
US Market

iCAD (ICAD) Earnings Dates, Call Summary & Reports

Compare
439 Followers

Earnings Data

Report Date
May 19, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.06
Last Year’s EPS
-0.05
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 19, 2025
|
% Change Since: -10.93%
|
Next Earnings Date:May 19, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for iCAD with strong revenue growth, successful SaaS transition, and significant advancements in AI technology and global partnerships. However, financial challenges such as increased operating expenses and net losses are present due to strategic investments and the SaaS transition.
Company Guidance
During the iCAD Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call, Dana Brown, the CEO, reported a strong quarter with revenue surpassing expectations at $5.4 million, leading to an annual revenue of $19.6 million and an annual recurring revenue (ARR) of $9.8 million. The company achieved significant milestones, such as receiving FDA clearance for ProFound Detection version 4.0, which improved cancer detection by 22% and reduced false positives by 18%. The transition to a software-as-a-service model is reshaping revenue generation, with 19 cloud deals closed in Q4, compared to previous quarters. The company's SaaS transition is expected to enhance financial predictability, with ARR growing 11% year-over-year. Despite some lumpiness in revenue recognition due to the SaaS transition, iCAD reported a GAAP net loss of $0.9 million for Q4 while maintaining a strong cash position of $17.2 million. The company is focused on expanding its SaaS footprint, driving innovation, and leveraging partnerships to continue its growth trajectory in 2025.
Revenue Growth
Fourth quarter revenue reached $5.4 million, marking a 14% increase over the fourth quarter of 2023. Full-year revenue for 2024 was $19.6 million, up from $17.3 million in 2023.
Annual Recurring Revenue (ARR) Increase
Total ARR increased to $9.8 million at the end of the fourth quarter of 2024, up from $8.8 million at the end of the fourth quarter of 2023. Subscription ARR increased from $1.7 million to $2.6 million year-over-year.
Successful SaaS Transition
iCAD made significant progress in transitioning to a SaaS-based model, reporting strong cloud adoption with 19 cloud deals in Q4, up from 13 in Q3 and 10 in Q2.
FDA Clearance of ProFound Detection Version 4.0
The new version offers a 22% improvement in detecting aggressive cancers, with a 50% increase in sensitivity for dense breast tissue and a 60% improvement in identifying invasive lobular cancers.
Global Expansion and Partnerships
Signed new distribution agreements in South Africa and Portugal, and a significant deal with Sectra in the UK. Also secured regulatory approval in Jordan.
---

iCAD (ICAD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ICAD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 19, 20252025 (Q1)
-0.06 / -
-0.05
Mar 19, 20252024 (Q4)
-0.05 / -0.03
-0.02-50.00% (>-0.01)
Nov 13, 20242024 (Q3)
-0.08 / -0.07
-0.04-75.00% (-0.03)
Aug 13, 20242024 (Q2)
-0.07 / -0.07
-0.070.00% (0.00)
May 15, 20242024 (Q1)
-0.06 / -0.05
-0.1464.29% (+0.09)
Mar 12, 20242023 (Q4)
-0.06 / -0.02
-0.1283.33% (+0.10)
Nov 13, 20232023 (Q3)
-0.09 / -0.04
-0.1573.33% (+0.11)
Aug 14, 20232023 (Q2)
-0.11 / -0.07
-0.1241.67% (+0.05)
May 15, 20232023 (Q1)
-0.11 / -0.14
-0.140.00% (0.00)
Mar 28, 20232022 (Q4)
-0.15 / -0.12
-0.1729.41% (+0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ICAD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 19, 2025$2.47$2.09-15.38%
Nov 13, 2024$2.34$1.78-23.93%
Aug 13, 2024$1.36$1.40+2.94%
May 15, 2024$1.63$1.77+8.59%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does iCAD Inc (ICAD) report earnings?
iCAD Inc (ICAD) is schdueled to report earning on May 19, 2025, TBA Not Confirmed.
    What is iCAD Inc (ICAD) earnings time?
    iCAD Inc (ICAD) earnings time is at May 19, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ICAD EPS forecast?
          ICAD EPS forecast for the fiscal quarter 2025 (Q1) is -0.06.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis